BARCELONA, Sept 3 (Reuters) - Spanish drugmaker Grifols

postponed indefinitely a meeting with investors and

analysts dubbed 'investors day' that was originally scheduled on

Oct. 10, a document sent to investors and seen by Reuters said

on Tuesday.

Grifols said it made the decision in light of the potential

delisting offer for Grifols' shares being evaluated by Canadian

fund Brookfield and the Grifols founding family.

They are currently in the process of a due diligence and at

this time "there is no offer, agreement, or decision regarding

the potential transaction or its related terms and conditions

nor is there any guarantee or commitment that an offer for

Grifols' shares will be made," the document added.

(Reporting by Joan Faus, editing by Inti Landauro)